Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia (Q62110880)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia |
clinical trial |
Statements
Treatment of Relapsed Acute Myelogenous Leukemia Consisting of Intermediate Dose Cytosine Arabinoside (ARA-C) Plus Interspaced Continuous Infusion Idarubicin, Followed by Continuous Infusion of Low-Dose ARA-C, A Phase II Study by the EORTC-LCG (English)
0 references
December 1998
0 references
60
0 references